Jupyter and Galaxy: Easing entry barriers into complex data analyses for biomedical researchers
Date
2017
Type:
Artículo
item.page.extent
10
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
PLoS
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
What does it take to convert a heap of sequencing data into a publishable result? First, common
tools are employed to reduce primary data (sequencing reads) to a form suitable for further
analyses (i.e., the list of variable sites). The subsequent exploratory stage is much
more ad hoc and requires the development of custom scripts and pipelines, making it problematic
for biomedical researchers. Here, we describe a hybrid platform combining common
analysis pathways with the ability to explore data interactively. It aims to fully encompass
and simplify the "raw data-to-publication" pathway and make it reproducible.
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
PLoS Comput Biol. 2017 May; 13(5): e1005425
Keywords
Biomedical Research/methods, Biomedical Research/organization & administration, Computational Biology, High-Throughput Nucleotide Sequencing, Humans, Research Personnel, Software